Definium Therapeutics, Inc. (DFTX) income statement
DFTXNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$29.12−0.26 (-0.88%)
Close on Nov 18, 2026Market cap $3.91BP/E –Yield –
Definium Therapeutics, Inc. financial ratios
See a number that looks wrong?